CJ Bio Malaysia Sdn Bhd (CJBM) is a joint-venture between CJ CheilJedang Corporation from South Korea and the Arkema Group from France (minor shareholder). This joint venture created a synergy worth at least RM 4.2 billion (in 2023) and it is the largest industrial biotechnology investment to date in Malaysia. CJBM is the world's first and only commercial-scale producer of L-methionine, using cutting-edge microbial fermentation, biotechnology, and purification methods.Unlike conventional methods that use highly toxic compounds from non-renewable crude oil, CJ's L-methionine is produced through a double fermentation process with renewable resources, making it a green alternative.
CJ Bio Malaysia Sdn Bhd (CJBM) is a joint-venture between CJ CheilJedang Corporation from South Korea and the Arkema Group from France (minor shareholder). This joint venture created a synergy worth at least RM 4.2 billion (in 2023) and it is the largest industrial biotechnology investment to date in Malaysia. CJBM is the world's first and only commercial-scale producer of L-methionine, using cutting-edge microbial fermentation, biotechnology, and purification methods.Unlike conventional methods that use highly toxic compounds from non-renewable crude oil, CJ's L-methionine is produced through a double fermentation process with renewable resources, making it a green alternative.
CJ Bio Malaysia Sdn Bhd (CJBM) is a joint-venture between CJ CheilJedang Corporation from South Korea and the Arkema Group from France (minor shareholder). This joint venture created a synergy worth at least RM 4.2 billion (in 2023) and it is the largest industrial biotechnology investment to date in Malaysia. CJBM is the world's first and only commercial-scale producer of L-methionine, using cutting-edge microbial fermentation, biotechnology, and purification methods.Unlike conventional methods that use highly toxic compounds from non-renewable crude oil, CJ's L-methionine is produced through a double fermentation process with renewable resources, making it a green alternative.